2533 (2533) Fair Value & Analysis

Technology · Market cap HK$7.8B

2 2533 2533 · HK

PriceHK$11.40

Fair ValueHK$6.75

Upside-40.8%

Quality31/100

Watch 2533 for free — get notified when fair value or trend changes. Watch for free

Evidence: Low Range HK$4.47 – HK$8.47

Fair value as of: Jul 2, 2026

From 1 valuation models · updated today

Share price −26.5% over the past month.

Price vs Fair Value (12 months)

12‑month range HK$10.38 – HK$25.10 · fair‑value band HK$4.47 – HK$8.47 · the HK$11.40 price screens above the HK$6.75 fair value. As of Jul 2, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

2533 (2533) currently trades at HK$11.40, while our model-based Fair Value estimate is HK$6.75 — implying the stock looks roughly 40.8% overvalued today. We read business quality at 31/100 (below-average quality), in the Technology sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

Trailing-twelve-month revenue stands at HK$822M. Revenue grew 93.6% year over year. The balance sheet holds a net cash position of HK$668M. Fundamentals as of Jul 2, 2026

Key figures & financial health

Revenue (TTM) HK$822M

Revenue growth (YoY) +93.6%

Net margin -173%

Return on equity -127%

Free cash flow −HK$1.0B FY2025

Operating margin -120%

More key figures

EPS (TTM) HK$-1.30

Net cash HK$668M FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 2, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

2533 reported revenue of HK$822M in FY2025 versus HK$60.5M in FY2021, a compound +92.0%/yr. Reported net income was −HK$1.4B in FY2025.

Revenue +92.0%/yr

FY21 HK$60.5M

FY22 HK$165M

FY23 HK$312M

FY24 HK$474M

FY25 HK$822M

Net income

FY21 −HK$2.4B

FY22 −HK$2.8B

FY23 −HK$4.9B

FY24 HK$313M

FY25 −HK$1.4B

Is 2533 fairly valued? → Check now

Similar stocks

6 more Semiconductors stocks, each showing price versus our Fair Value estimate (as of Jul 2, 2026).

Stock	Price	Fair Value	vs Fair Value
NVIDIA Corporation NVDA	$205.10	$115.06	-44%
Taiwan Semiconductor Manufacturing Company TSMN	7,419 MXN	5,870 MXN	-21%
Broadcom Inc 1YD	€324.55	€98.73	-70%
Micron Technology, Inc ZMIC	C$52.57	C$7.68	-85%
Advanced Micro Devices, Inc AMD	$551.63	$53.17	-90%
SK hynix Inc 000660	1,000,000 KRW	1,027,941 KRW	+3%

Explore undervalued stocks

More undervalued Technology stocks →

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks

Frequently asked questions

Is 2533 (2533) undervalued?

As of Jul 2, 2026, our model estimates a fair value of HK$6.75 versus a price of HK$11.40 — about −41% (overvalued). Model-based estimate, not financial advice.

What is the fair value of 2533?

Our model-based fair value for 2533 is HK$6.75 (as of Jul 2, 2026), built from audited fundamentals. The current price is HK$11.40.

What is the quality score of 2533?

2533 has a Quality Score of 31/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

What is the revenue of 2533 (2533)?

2533 reported trailing-twelve-month revenue of about HK$822M (latest available figure, as of Jul 2, 2026).

What is the net profit margin of 2533?

The net profit margin of 2533 is about -173.3%, meaning it is currently running at a net loss. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.